The process of developing an API typically involves several stages, including discovery, preclinical testing, and clinical trials. Once an API is developed and approved, it must be manufactured under stringent conditions in facilities that adhere to Good Manufacturing Practice (GMP) guidelines. Manufacturers must ensure that their APIs meet defined specifications for purity, potency, and consistency.
Sevoflurane is chemically classified as a fluorinated methyl isopropyl ether and is typically supplied in a 100 mL bottle. In its gaseous state, it is colorless and has a faint, pleasant odor, which enhances patient acceptance compared to other anesthetic agents. Its low blood-gas partition coefficient allows for rapid induction and emergence from anesthesia. This characteristic is particularly advantageous for outpatient procedures where minimizing recovery time is critical.